Furthermore, it could markedly suppress fibrosis, tumorigenesis, and cholestasis by inhibiting TGF-β signaling, the NF-κB pathway, and CYP7A1 activity (Figure 2). This evidence concerns the gene CYP7A1 and cholestasis.